Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Shares Take a Hit as BCW Index Falls Again

Shares in PerkinElmer fell 13.3 percent for the trading week ended Tuesday after reporting lackluster second quarter revenue growth and a fall in profits (see related article). Bruker also had a poor week, falling 7.6 percent ahead of its second-quarter results, which were released after the closing of trade on Tuesday. Beckman Coulter led gainers with a slight rise of 2.4 percent.
 
Overall, the Index fell 1.3 percent, following a 1-percent decline last week. In comparison, the Dow Jones Industrial Average gained .2 percent for the same period, the Nasdaq fell .6 percent, and the Nasdaq Biotech Index declined .3 percent.
 
 

BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(Aug 1, 2006)
Last Price
(July 25, 2006)
% change
Agilent
A
28.05
29.16
-3.8
Applied Biosystems
ABI
32.02
32.95
-2.8
Beckman
BEC
57.00
55.67
2.4
Bio-Rad
BIO
64.22
66.52
-3.5
Bruker
BRKR
5.51
5.96
-7.6
Fisher Scientific
FSH
74.70
73.61
1.5
GE
GE
32.56
32.70
-0.4
Invitrogen
IVGN
62.22
64.52
-3.6
Millipore
MIL
62.29
62.30
0.0
Molecular Devices
MDCC
23.39
23.80
-1.7
PerkinElmer
PKI
18.00
20.76
-13.3
Qiagen
QGEN
15.20
14.98
1.5
Sigma
SIAL
69.05
70.85
-2.5
Stratagene
STGN
6.48
6.60
-1.8
Thermo
TMO
37.14
36.63
1.4
Waters
WAT
40.26
39.57
1.7
BCW Index Average
39.26
39.79
-1.3
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.